Would 1.0 cm be a more suitable cutoff to subdivide pT1 tumors in hormone receptor‐negative and HER2‐positive breast cancer?

BACKGROUND: HER2+ and hormone receptor (HoR)‐negative breast cancer usually associated with poor outcome. However, it remained elusive for the prognosis of small (T1a‐T1c) HER2+/HoR‐ breast cancer. The present study retrospectively analyzed the Surveillance, Epidemiology, and End Results (SEER) data...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Changjun, Zhou, Yidong, Zhu, Hanjiang, Huang, Wei, Chen, Ziyuan, Mao, Feng, Lin, Yan, Zhang, Xiaohui, Shen, Songjie, Zhong, Ying, Li, Yan, Sun, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246936/
https://www.ncbi.nlm.nih.gov/pubmed/30277006
http://dx.doi.org/10.1002/cam4.1785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246936/
https://www.ncbi.nlm.nih.gov/pubmed/30277006
http://dx.doi.org/10.1002/cam4.1785

Ejemplares similares